Nucleic Acid Detection Immunoassay for Prostate-Specific Antigen Based on Immuno-PCR Methodology von MCDERMED, Jonathan E, SANDERS, Ron, FAIT, Stephen, KLEM, Robert E, SARNO, Mark J, ADAMS, Thomas H, DIAMANDIS, Eleftherios P

Volltext

NADiA ProsVue Prostate-specific Antigen Slope, CAPRA-S, and Prostate Cancer–specific Survival After Radical Prostatectomy von Moul, Judd W, Sarno, Mark J, McDermed, Jonathan E, Triebell, Melissa T, Reynolds, Mark A

Volltext

NADiA ProsVue Prostate-specific Antigen Slope Is an Independent Prognostic Marker for Identifying Men at Reduced Risk of Clinical Recurrence of Prostate Cancer After Radical Prosta... von Moul, Judd W, Lilja, Hans, Semmes, O. John, Lance, Raymond S, Vessella, Robert L, Fleisher, Martin, Mazzola, Clarisse, Sarno, Mark J, Stevens, Barbara, Klem, Robert E, McDermed, Jonathan E, Triebell, Melissa T, Adams, Thomas H

Volltext

Intermittent Androgen Deprivation in Prostate Cancer Patients: Factors Predictive of Prolonged Time Off Therapy von Strum, Stephen B., Scholz, Mark C., McDermed, Jonathan E.

Volltext

Reply von Moul, Judd W., McDermed, Jonathan E.

Volltext

Reply von Moul, Judd W., M.D, McDermed, Jonathan E., Ph.D

Volltext

Value of NADiA ProsVue on the CAPRA-S nomogram for predicting postprostatectomy clinical recurrence von Moul, Judd W., Lilja, Hans, Lance, Raymond, Vessella, Robert, McDermed, Jonathan E., Sarno, Mark J., Adams, Thomas H.

Volltext

Post-prostatectomy PSA slope (ProsVue) in Gleason score ≥7 disease von Moul, Judd W., Lilja, Hans, Semmes, Oliver John, Vessella, Robert, McDermed, Jonathan E., Sarno, Mark J., Klem, Robert E.

Volltext

NADiA® ProsVue™ PSA Slope Is an Independent Prognostic Marker for Identifying Men at Reduced Risk for Clinical Recurrence of Prostate Cancer after Radical Prostatectomy von Moul, Judd W., Lilja, Hans, Semmes, O. John, Lance, Raymond S., Vessella, Robert L., Fleisher, Martin, Mazzola, Clarisse, Sarno, Mark J., Stevens, Barbara, Klem, Robert E., McDermed, Jonathan E., Triebell, Melissa T., Adams, Thomas H.

Volltext

Clinical Pharmacokinetics of High-Dose Metoclopramide in Cancer Patients Receiving Cisplatin Therapy von McDermed, Jonathan E., Cohen, Jordan L., Joseph, Corrine, Strum, Stephen B.

Volltext

Oral Metoclopramide With or Without Diphenhydramine: Potential for Prevention of Late Nausea and Vomiting Induced by Cisplatin von Grunberg, Steven M., Ehler, Elizabeth, McDermed, Jonathan E., Akerley, Wallace L.

Volltext

METHOD FOR DETERMINING RECURRENCE OR STABLE DISEASE AFTER TREATMENT FOR PROSTATE CANCER von MCDERMED JONATHAN E, SAMO MARK J, JABLONSKI EDWARD, ADAMS THOMAS, KLEM ROBERT E, SAUNDERS RUSS

Volltext bestellen

METHOD FOR DETERMINING LIKELIHOOD OF CLINICAL RECURRENCE OR CLINICALLY STABLE DISEASE OF PROSTATE CANCER AFTER RADICAL PROSTATECTOMY von MCDERMED JONATHAN E, SARNO MARK J, JABLONSKI EDWARD, KLEM ROBERT E, ADAMS THOMAS H, SAUNDERS RUSSELL

Volltext bestellen

Intravenous metoclopramide: Prevention of chemotherapy‐induced nausea and vomiting. A preliminary evaluation von Strum, Stephen B., McDermed, Jonathan E., Pileggi, Joanne, Riech, Laraine P., Whitaker, Helen

Volltext

Examination of the correlation of serum metoclopramide levels with antiemetic efficacy in patients receiving cisplatin von GRUNBERG, S. M, MCDERMED, J. E, BERNSTEIN, L, COHEN, J. L

Volltext

Intrathoracic Hodgkin's disease a case presentation with multiple pulmonary nodules in the absence of mediastinal or Hilar node disease von Strum, Stephen B., Weiss, Alan, McDermed, Jonathan E., Rosen, Victor J.

Volltext

Treatment of astrocytoma with a 5-day cisplatin infusion von GRUNBERG, S. M, BERTRAM, J. H, MCDERMED, J. E, APUZZO, M. L. J

Volltext